Jan 27, 2025 | Federal Trade Commission (FTC), MedBen Rx, News, Pharmacy Benefits Manager (PBM), Rx Costs, Specialty Drugs, Spread Pricing
Through specialty generic drug markups, three major pharmacy benefit managers (PBMs) earned a collective $7.3 billion above estimated acquisition costs over a five-year period, according to an interim report released by the Federal Trade Commission (FTC)....
Jan 10, 2025 | Drug costs, Drug reimportation, News
Pharmaceutical companies are planning to increase prices on over 250 brand-name medications in the United States at the beginning of 2025, according to an analysis by health care research firm 3 Axis Advisors. That’s a notable drop from last January, during...
Aug 30, 2024 | Compliance, Employee Retirement Income Security Act (ERISA), Legislative, News, Regulatory
50 years ago – on September 2, 1974 – ERISA was signed into law by President Gerald R. Ford. The Employee Retirement Income Security Act has had a profound impact on how health benefits are provided to most working Americans. Despite its impact, the legislation...
Aug 2, 2024 | Cancer, Colon Cancer, Colonoscopy, Food and Drug Administration (FDA), News, Preventive Care, Research, Wellness
On July 29, the Food and Drug Administration approved a first-of-its-kind blood test determined to be 83% effective at detecting colon cancer. Called Shield, the noninvasive test was authorized for use by people aged 45 and older with an “average risk” of the...
Jul 23, 2024 | Federal Trade Commission (FTC), Formularies, News, Pharmacy Benefits Manager (PBM)
In an interim report released on July 9, the Federal Trade Commission charges major pharmacy benefit managers of engaging in business practices designed to benefit their own bottom lines at the expense of clients. The FTC report, subtitled “The Powerful...
Jul 8, 2024 | Affordable Care Act, Compliance, Department of Health and Human Services (HHS), Department of Labor, News, Regulatory, Supreme Court, Treasury Department
Last month, in a 6 to 3 decision, the U.S. Supreme Court overturned the “Chevron Deference” doctrine. The Chevron Deference is a principle of administrative law that has required courts to defer to how regulatory agencies interpret federal statutes (legislation...
